SADIE BLACKWELL: Open Payments
NPI 1942857776 · NORTH LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 28 payments from 8 companies in 2025. Trend: 2023 $600 · 2024 $466 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $150 |
| ABBVIE INC. | 4 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Alkermes, Inc. | 1 | $22 |
Products named: SPRAVATO, VRAYLAR, TRINTELLIX, REXULTI, CAPLYTA, Auvelity, FANAPT, HETLIOZ.
Industry payments across AR — which companies pay providers there.
